#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Indolent systemic mastocytosis Fms-like tyrosine kinase 3 positive Congenital growth hormone deficiency Brain stem glioma Synovial sarcoma Osteosarcoma recurrent Homocystinuria Colon cancer Extra-osseous Ewing's sarcoma recurrent Endometrial cancer Pituitary-dependent Cushing's syndrome Chronic hepatitis B Huntington's disease Neurotrophic keratopathy More trials…

    Learn about Rare Diseases

    Piriformis syndrome Uterine leiomyosarcoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Cytokine release syndrome – Treatment Proteus syndrome – Treatment Indolent systemic mastocytosis – Diagnostics Ewing’s sarcoma – Trials in Disease Basal cell naevus syndrome – Basic Information Ewing’s sarcoma recurrent – Basic Information Progressive supranuclear palsy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ILOPROST Lna043 Zongertinib Prednisolone Sodium Phosphate Cefoxitin Baloxavir Marboxil Zilucoplan Sodium Mesalazine Fidanacogene Elaparvovec VX-407 Ptg-Carcik-Cd19 Darbepoetin Alfa Gefitinib AZD4512 Iclepertin GRAPHITE CARBOMER 980 Bintrafusp Alfa Ab-729 Doxorubicin Hydrochloride More therapies…

    Learn about Your Condition

    Schizoaffective disorder Brain injury MELAS syndrome Actinic cheilitis Cortical dysplasia Testicular germ cell tumour Tuberculosis Andersen-Tawil syndrome Epidermolysis bullosa Oedema Nephropathy Coronary artery occlusion Lymphatic malformation Appendicitis perforated Hepatic angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Long-Term Safety and Effectiveness of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Losmapimod
    France Spain

  • Study on the Effects of QUC398 for Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Codeine Phosphate Hemihydrate
    • Quc398
    • Paracetamol
    Denmark France Spain

  • Study on Apocynin and Paeonol for Knee Osteoarthritis Pain Relief in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Apocynin
    • Paeonol
    • Paracetamol
    Denmark

  • Study on the Safety and Effectiveness of AT132 Gene Therapy for Patients with X-Linked Myotubular Myopathy

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Resamirigene Bilparvovec
    France Germany

  • Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Vesleteplirsen
    Belgium Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

    Not recruiting

    3 1
    Investigated Drugs:
    • Garetosmab
    Finland France Italy The Netherlands Poland Spain
Previous Page
1 … 53 54 55 56 57 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!